Researchers at Hospital for Special Surgery in New York City have identified a protein, known as IRHOM2, as the potential new target for drugs to treat patients with rheumatoid arthritis (RA). The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid …
Continue reading “New drug target for rheumatoid arthritis identified”